Osman Maaisha on Muck Rack

Osman Maaisha

As seen in: The Pink Sheet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Osman

Contact Osman, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

RFK Jr. Defends Makary’s US FDA Record, Refutes Claims Of Chilled Biopharma Investment

|
By Osman Maaisha
| The Pink Sheet Verified
Health and Human Services Secretary Robert F. Kennedy Jr. said criticism of FDA Commissioner Martin Makary stems from industry anger over tougher evidentiary standards. RFK Jr. defended FDA Commissioner Martin Makary's record during a House Ways and Means Committee hearing. (Screenshot of Committee Broadcast) Key Takeaways Rep. Darin LaHood, R-IL, warned that inconsistent FDA review decisions risk driving biopharma investment overseas, particularly to China.
Open in Who Shared Issue with article?

US FDA Peptide Review Signals Policy Shift, But Manufacturing, Regulatory Hurdles Persist

|
By Osman Maaisha
| The Pink Sheet Verified
The FDA’s Pharmacy Compounding Advisory Committee review of peptides is an early policy step, but rulemaking and manufacturing constraints may delay its impact. An FDA advisory committee will consider lifting restrictions on some peptides after the agency restricted them in 2023.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified